TPST · Tempest Therapeutics, Inc. · Executive Compensation
$0.81
+0.01 (+0.63%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We expect that our existing cash and cash equivalents will fund our projected operating expense requirements through less than 12 months from the date our consolidated financial statements were available to be issued. Accordingly, there is substantial doubt regarding our ability to continue as a going concern for a period of 12 months from the date of the issuance of the Consolidated Financial Statements included elsewhere in this Quarterly Report on Form 10-Q.”View the 10-Q filed Aug 13, 2026
Market Cap
$12.28M
Shares
14.81M
Volume · Oct 2
2.27M
Avg daily vol (3M)
2.59M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Stephen Brady | Chief Executive Officer and President | $1,872,299 |
| Samuel Whiting | Chief Medical Officer | $1,062,587 |
| Nicholas Maestas | Chief Financial Officer | $622,095 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Stephen Brady | Chief Executive Officer and President | $7,007,407 |
| Samuel Whiting | Chief Medical Officer | $3,384,949 |
| Nicholas Maestas | Chief Financial Officer | $1,319,038 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Stephen Brady | Chief Executive Officer and President | $1,514,366 |
| Thomas Dubensky | President | $1,100,586 |
| Samuel Whiting | Chief Medical Officer | $833,398 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Louis J. Arcudi III | Former Chief Executive Officer | $1,632,960 |
| Thomas Dubensky | President | $1,500,167 |
| Julia C. Owens | Former Chief Executive Officer | $1,339,793 |
| Samuel Whiting | Chief Medical Officer | $836,737 |
| Stephen Brady | Chief Executive Officer | $714,721 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Julia C. Owens | Former Chief Executive Officer | $2,281,928 |
| Louis J. Arcudi III | Former Chief Executive Officer | $976,240 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Julia C. Owens | Chief Executive Officer | $2,381,882 |
| Louis J. Arcudi III | Chief Financial Officer | $1,003,401 |
| Ryan Zeidan | Chief Development Officer | $849,145 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Julia C. Owens | Chief Executive Officer | $2,424,207 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Nancy Freda-Smith | Board of Directors | Appointed | 2026-09-28 |
| Constance Ames | Chief Financial Officer Principal Financial and Accounting Officer, Treasurer, and Corporate Secretary | Appointed | 2026-09-28 |
| Nicholas Rossettos | Chief Financial Officer | Resigned | 2026-09-28 |
| Nancy Freda-Smith | Class III director | Appointed | 2026-09-28 |
| Nicholas Rossettos | Chief Financial Officer Principal Financial and Accounting Officer, Treasurer, and Corporate Secretary | Appointed | 2026-08-24 |
| Justin Trojanowski | Principal Financial Officer and Principal Accounting Officer | Resigned | 2026-08-24 |
| John David Yee | Class II director | Appointed | 2026-06-04 |
| William Drake Richey | Class II director | Appointed | 2026-06-04 |
| Justin Trojanowski | Vice President, Finance, Principal Financial Officer and Corporate Secretary | Appointed | 2026-06-04 |
| Nicholas Maestas | Chief Financial Officer | Resigned | 2026-06-04 |
| Ms. Simantov | Board of Directors | Resigned | 2026-05-29 |
| Christine Pellizzari | Board of Directors | Resigned | 2026-05-22 |
| Michael Raab | Board of Directors | Resigned | 2026-05-22 |
| Stephen Brady | Board of Directors | Resigned | 2026-05-22 |
| Matt Angel | Class I director | Appointed | 2026-02-06 |
| Matt Angel | President and Chief Executive Officer | Appointed | 2026-02-06 |
| Stephen Brady | President and Chief Executive Officer of the Company | Resigned | 2026-02-06 |
| Stephen Brady | Chair of the Board | Appointed | 2026-02-06 |
| Geoff Nichol | Board | Resigned | 2026-02-06 |
| Geoff Nichol | Class I director | Appointed | 2026-01-28 |
| Matt Angel, Ph.D. | Class I director | Appointed | 2025-11-19 |
| Matt Angel, Ph.D. | President and Chief Executive Officer | Appointed | 2025-11-19 |
| Stephen Brady | Chairman of the Company's board of directors | Appointed | 2025-11-19 |
| Geoff Nichol | board of directors of the Company | Resigned | 2025-11-19 |
| Matt Angel | member of the Company's board of directors | Appointed | 2025-11-19 |